Intractable Crohn's colitis and perianal disease responding to cyclophosphamide and epirubicin

Nick Rieger; Jurgen Stahl; David Wattchow

doi:10.1023/A:1018843507275

Intractable Crohn's colitis and perianal disease responding to cyclophosphamide and epirubicin

Nick Rieger
, Jurgen Stahl
, David Wattchow

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

A case is reported where intractable Crohn's disease responded to chemotherapy for breast carcinoma. The drug most likely responsible was cyclophosphamide. Cyclophosphamide may have a role in the management of inflammatory bowel disease, but this needs to be confirmed before it can be recommended as a treatment option.

Original language	English
Pages (from-to)	2367-2369
Number of pages	3
Journal	Digestive Diseases and Sciences
Volume	42
Issue number	11
DOIs	https://doi.org/10.1023/A:1018843507275
Publication status	Published - Nov 1997
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Crohn's disease
Cyclophosphamide

Access to Document

10.1023/A:1018843507275Licence: In Copyright

Cite this

@article{f252dcf877b74d0289543ae746b9020c,

title = "Intractable Crohn's colitis and perianal disease responding to cyclophosphamide and epirubicin",

abstract = "A case is reported where intractable Crohn's disease responded to chemotherapy for breast carcinoma. The drug most likely responsible was cyclophosphamide. Cyclophosphamide may have a role in the management of inflammatory bowel disease, but this needs to be confirmed before it can be recommended as a treatment option.",

keywords = "Crohn's disease, Cyclophosphamide",

author = "Nick Rieger and Jurgen Stahl and David Wattchow",

year = "1997",

month = nov,

doi = "10.1023/A:1018843507275",

language = "English",

volume = "42",

pages = "2367--2369",

journal = "Digestive Diseases and Sciences",

issn = "0163-2116",

publisher = "Springer",

number = "11",

}

TY - JOUR

T1 - Intractable Crohn's colitis and perianal disease responding to cyclophosphamide and epirubicin

AU - Rieger, Nick

AU - Stahl, Jurgen

AU - Wattchow, David

PY - 1997/11

Y1 - 1997/11

N2 - A case is reported where intractable Crohn's disease responded to chemotherapy for breast carcinoma. The drug most likely responsible was cyclophosphamide. Cyclophosphamide may have a role in the management of inflammatory bowel disease, but this needs to be confirmed before it can be recommended as a treatment option.

AB - A case is reported where intractable Crohn's disease responded to chemotherapy for breast carcinoma. The drug most likely responsible was cyclophosphamide. Cyclophosphamide may have a role in the management of inflammatory bowel disease, but this needs to be confirmed before it can be recommended as a treatment option.

KW - Crohn's disease

KW - Cyclophosphamide

UR - https://www.scopus.com/pages/publications/0031436255

U2 - 10.1023/A:1018843507275

DO - 10.1023/A:1018843507275

M3 - Article

C2 - 9398818

AN - SCOPUS:0031436255

SN - 0163-2116

VL - 42

SP - 2367

EP - 2369

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

IS - 11

ER -

Intractable Crohn's colitis and perianal disease responding to cyclophosphamide and epirubicin

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this